bioAffinity Technologies Files 8-K on Security Holder Vote Matters
Ticker: BIAFW · Form: 8-K · Filed: Jul 25, 2025 · CIK: 1712762
| Field | Detail |
|---|---|
| Company | Bioaffinity Technologies, INC. (BIAFW) |
| Form Type | 8-K |
| Filed Date | Jul 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, disclosure
Related Tickers: BIAF
TL;DR
BIAF filed an 8-K for a shareholder vote - expect news on corporate decisions soon.
AI Summary
On July 25, 2025, bioAffinity Technologies, Inc. filed an 8-K report detailing a submission of matters to a vote of security holders. The company, incorporated in Delaware, is involved in commercial physical and biological research.
Why It Matters
This filing indicates that bioAffinity Technologies, Inc. is engaging its security holders in decisions, which could impact corporate governance and future strategic directions.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a shareholder vote matter, not indicating immediate financial distress or significant operational changes.
Key Numbers
- 001-41463 — SEC File Number (Identifies the company's filing history with the SEC.)
- 46-5211056 — EIN (Employer Identification Number for tax purposes.)
Key Players & Entities
- bioAffinity Technologies, Inc. (company) — Registrant
- July 25, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 8731 (sic_code) — Standard Industrial Classification
FAQ
What specific matters are being submitted for a vote of security holders?
The filing states it is a 'Submission of Matters to a Vote of Security Holders' but does not specify the exact proposals in the provided text.
When was this 8-K report filed?
The report was filed on July 25, 2025.
What is the principal business of bioAffinity Technologies, Inc.?
The company is engaged in 'SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH' with SIC code 8731.
Where is bioAffinity Technologies, Inc. headquartered?
The company's principal executive offices are located at 3300 Nacogdoches Road, Suite 216, San Antonio, Texas 78257.
What is the company's fiscal year end?
The company's fiscal year ends on December 31st.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 25, 2025 regarding bioAffinity Technologies, Inc. (BIAFW).